Biologics and Cell Therapy Tissue Engineering Approaches for the Management of the Edentulous Maxilla: A Systematic Review.
Identifieur interne : 000262 ( PubMed/Curation ); précédent : 000261; suivant : 000263Biologics and Cell Therapy Tissue Engineering Approaches for the Management of the Edentulous Maxilla: A Systematic Review.
Auteurs : Gustavo Avila-Ortiz ; P Mark Bartold ; William Giannobile ; Wataru Katagiri ; Salvador Nares ; Hector Rios ; Daniel Spagnoli ; Ulf Me WikesjöSource :
- The International journal of oral & maxillofacial implants [ 1942-4434 ] ; 2016.
Descripteurs français
- KwdFr :
- Bouche édentée (), Facteur de croissance transformant bêta (usage thérapeutique), Humains, Implants dentaires, Ingénierie tissulaire (), Maxillaire (), Maxillaire (anatomopathologie), Plasma riche en plaquettes, Pose d'implant dentaire endo-osseux (), Produits biologiques (usage thérapeutique), Protéine morphogénétique osseuse de type 2 (usage thérapeutique), Protéines recombinantes (usage thérapeutique), Reconstruction de crête alvéolaire (), Sinus maxillaire (), Thérapie cellulaire et tissulaire (), Transplantation osseuse ().
- MESH :
- anatomopathologie : Maxillaire.
- usage thérapeutique : Facteur de croissance transformant bêta, Produits biologiques, Protéine morphogénétique osseuse de type 2, Protéines recombinantes.
- Bouche édentée, Humains, Implants dentaires, Ingénierie tissulaire, Maxillaire, Plasma riche en plaquettes, Pose d'implant dentaire endo-osseux, Reconstruction de crête alvéolaire, Sinus maxillaire, Thérapie cellulaire et tissulaire, Transplantation osseuse.
English descriptors
- KwdEn :
- Alveolar Ridge Augmentation (methods), Biological Products (therapeutic use), Bone Morphogenetic Protein 2 (therapeutic use), Bone Transplantation (methods), Cell- and Tissue-Based Therapy (methods), Dental Implantation, Endosseous (methods), Dental Implants, Humans, Maxilla (pathology), Maxilla (surgery), Maxillary Sinus (surgery), Mouth, Edentulous (surgery), Platelet-Rich Plasma, Recombinant Proteins (therapeutic use), Tissue Engineering (methods), Transforming Growth Factor beta (therapeutic use).
- MESH :
- chemical , therapeutic use : Biological Products, Bone Morphogenetic Protein 2, Recombinant Proteins, Transforming Growth Factor beta.
- methods : Alveolar Ridge Augmentation, Bone Transplantation, Cell- and Tissue-Based Therapy, Dental Implantation, Endosseous, Tissue Engineering.
- pathology : Maxilla.
- surgery : Maxilla, Maxillary Sinus, Mouth, Edentulous.
- chemical : Dental Implants, Humans, Platelet-Rich Plasma.
Abstract
The aim of this systematic review was to evaluate current and emerging regenerative approaches for implant site development in the edentulous atrophic maxilla using tissue engineering and regenerative medicine (TERM) principles and to identify priorities for future research.
PubMed: 27228246
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000262
Links to Exploration step
pubmed:27228246Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Biologics and Cell Therapy Tissue Engineering Approaches for the Management of the Edentulous Maxilla: A Systematic Review.</title><author><name sortKey="Avila Ortiz, Gustavo" sort="Avila Ortiz, Gustavo" uniqKey="Avila Ortiz G" first="Gustavo" last="Avila-Ortiz">Gustavo Avila-Ortiz</name></author><author><name sortKey="Bartold, P Mark" sort="Bartold, P Mark" uniqKey="Bartold P" first="P Mark" last="Bartold">P Mark Bartold</name></author><author><name sortKey="Giannobile, William" sort="Giannobile, William" uniqKey="Giannobile W" first="William" last="Giannobile">William Giannobile</name></author><author><name sortKey="Katagiri, Wataru" sort="Katagiri, Wataru" uniqKey="Katagiri W" first="Wataru" last="Katagiri">Wataru Katagiri</name></author><author><name sortKey="Nares, Salvador" sort="Nares, Salvador" uniqKey="Nares S" first="Salvador" last="Nares">Salvador Nares</name></author><author><name sortKey="Rios, Hector" sort="Rios, Hector" uniqKey="Rios H" first="Hector" last="Rios">Hector Rios</name></author><author><name sortKey="Spagnoli, Daniel" sort="Spagnoli, Daniel" uniqKey="Spagnoli D" first="Daniel" last="Spagnoli">Daniel Spagnoli</name></author><author><name sortKey="Wikesjo, Ulf Me" sort="Wikesjo, Ulf Me" uniqKey="Wikesjo U" first="Ulf Me" last="Wikesjö">Ulf Me Wikesjö</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27228246</idno><idno type="pmid">27228246</idno><idno type="wicri:Area/PubMed/Corpus">000262</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000262</idno><idno type="wicri:Area/PubMed/Curation">000262</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000262</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Biologics and Cell Therapy Tissue Engineering Approaches for the Management of the Edentulous Maxilla: A Systematic Review.</title><author><name sortKey="Avila Ortiz, Gustavo" sort="Avila Ortiz, Gustavo" uniqKey="Avila Ortiz G" first="Gustavo" last="Avila-Ortiz">Gustavo Avila-Ortiz</name></author><author><name sortKey="Bartold, P Mark" sort="Bartold, P Mark" uniqKey="Bartold P" first="P Mark" last="Bartold">P Mark Bartold</name></author><author><name sortKey="Giannobile, William" sort="Giannobile, William" uniqKey="Giannobile W" first="William" last="Giannobile">William Giannobile</name></author><author><name sortKey="Katagiri, Wataru" sort="Katagiri, Wataru" uniqKey="Katagiri W" first="Wataru" last="Katagiri">Wataru Katagiri</name></author><author><name sortKey="Nares, Salvador" sort="Nares, Salvador" uniqKey="Nares S" first="Salvador" last="Nares">Salvador Nares</name></author><author><name sortKey="Rios, Hector" sort="Rios, Hector" uniqKey="Rios H" first="Hector" last="Rios">Hector Rios</name></author><author><name sortKey="Spagnoli, Daniel" sort="Spagnoli, Daniel" uniqKey="Spagnoli D" first="Daniel" last="Spagnoli">Daniel Spagnoli</name></author><author><name sortKey="Wikesjo, Ulf Me" sort="Wikesjo, Ulf Me" uniqKey="Wikesjo U" first="Ulf Me" last="Wikesjö">Ulf Me Wikesjö</name></author></analytic><series><title level="j">The International journal of oral & maxillofacial implants</title><idno type="eISSN">1942-4434</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alveolar Ridge Augmentation (methods)</term><term>Biological Products (therapeutic use)</term><term>Bone Morphogenetic Protein 2 (therapeutic use)</term><term>Bone Transplantation (methods)</term><term>Cell- and Tissue-Based Therapy (methods)</term><term>Dental Implantation, Endosseous (methods)</term><term>Dental Implants</term><term>Humans</term><term>Maxilla (pathology)</term><term>Maxilla (surgery)</term><term>Maxillary Sinus (surgery)</term><term>Mouth, Edentulous (surgery)</term><term>Platelet-Rich Plasma</term><term>Recombinant Proteins (therapeutic use)</term><term>Tissue Engineering (methods)</term><term>Transforming Growth Factor beta (therapeutic use)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Bouche édentée ()</term><term>Facteur de croissance transformant bêta (usage thérapeutique)</term><term>Humains</term><term>Implants dentaires</term><term>Ingénierie tissulaire ()</term><term>Maxillaire ()</term><term>Maxillaire (anatomopathologie)</term><term>Plasma riche en plaquettes</term><term>Pose d'implant dentaire endo-osseux ()</term><term>Produits biologiques (usage thérapeutique)</term><term>Protéine morphogénétique osseuse de type 2 (usage thérapeutique)</term><term>Protéines recombinantes (usage thérapeutique)</term><term>Reconstruction de crête alvéolaire ()</term><term>Sinus maxillaire ()</term><term>Thérapie cellulaire et tissulaire ()</term><term>Transplantation osseuse ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Biological Products</term><term>Bone Morphogenetic Protein 2</term><term>Recombinant Proteins</term><term>Transforming Growth Factor beta</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Maxillaire</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Alveolar Ridge Augmentation</term><term>Bone Transplantation</term><term>Cell- and Tissue-Based Therapy</term><term>Dental Implantation, Endosseous</term><term>Tissue Engineering</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Maxilla</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Maxilla</term><term>Maxillary Sinus</term><term>Mouth, Edentulous</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Facteur de croissance transformant bêta</term><term>Produits biologiques</term><term>Protéine morphogénétique osseuse de type 2</term><term>Protéines recombinantes</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Dental Implants</term><term>Humans</term><term>Platelet-Rich Plasma</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Bouche édentée</term><term>Humains</term><term>Implants dentaires</term><term>Ingénierie tissulaire</term><term>Maxillaire</term><term>Plasma riche en plaquettes</term><term>Pose d'implant dentaire endo-osseux</term><term>Reconstruction de crête alvéolaire</term><term>Sinus maxillaire</term><term>Thérapie cellulaire et tissulaire</term><term>Transplantation osseuse</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this systematic review was to evaluate current and emerging regenerative approaches for implant site development in the edentulous atrophic maxilla using tissue engineering and regenerative medicine (TERM) principles and to identify priorities for future research.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27228246</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1942-4434</ISSN><JournalIssue CitedMedium="Internet"><Volume>31 Suppl</Volume><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>The International journal of oral & maxillofacial implants</Title><ISOAbbreviation>Int J Oral Maxillofac Implants</ISOAbbreviation></Journal><ArticleTitle>Biologics and Cell Therapy Tissue Engineering Approaches for the Management of the Edentulous Maxilla: A Systematic Review.</ArticleTitle><Pagination><MedlinePgn>s121-64</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.11607/jomi.16suppl.g4</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this systematic review was to evaluate current and emerging regenerative approaches for implant site development in the edentulous atrophic maxilla using tissue engineering and regenerative medicine (TERM) principles and to identify priorities for future research.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Two independent examiners conducted a comprehensive search using specific keywords to identify original clinical studies using TERM for implant site development in the edentulous atrophic maxilla including indications for alveolar ridge preservation, horizontal alveolar augmentation, maxillary sinus augmentation, and augmentation of severe vertical or combined defects. Endpoints included clinical, radiographic, histologic, and patient-centered outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The initial search identified 3,061 articles. The final selection included 89 articles, of which 12 evaluated alveolar ridge preservation, 6 horizontal defects, 61 maxillary sinus augmentation, and 11 management of severe vertical or combined defects. A summary of the main findings relative to the effect of TERM-based approaches applied for implant site development in the atrophic maxillary segments is presented. Marked heterogeneity among included studies prevented meaningful quantitative analysis. The following relevant effects of TERM-based therapies for site development in the edentulous atrophic maxilla were observed: (1) recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge carrier increased bone augmentation; (2) recombinant human platelet-derived growth factor BB in combination with freeze-dried bone allograft or beta tricalcium phosphate accelerated bone formation through accelerated remodeling of carrier biomaterials; (3) autologous cell therapy enhanced clinical and radiographic outcomes; (4) autologous cell therapy in alveolar ridge preservation provided superior histomorphometric outcomes (vital bone formation) at 6 weeks; and (5) platelet-rich plasma formulations combined with autologous bone grafts for maxillary sinus augmentation increased radiographic density and accelerated bone mineralization at 6 months.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Clinical success has been demonstrated with the application of different TERM modalities for implant site development in the edentulous atrophic maxilla. However, indications are narrow and further study is needed. Clinical trials assessing meaningful outcomes, involving larger populations, and with longer follow-up are warranted to discern the effectiveness of the achieved results compared with a valid control.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Avila-Ortiz</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Bartold</LastName><ForeName>P Mark</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Giannobile</LastName><ForeName>William</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Katagiri</LastName><ForeName>Wataru</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Nares</LastName><ForeName>Salvador</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Rios</LastName><ForeName>Hector</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Spagnoli</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Wikesjö</LastName><ForeName>Ulf Me</ForeName><Initials>UM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Oral Maxillofac Implants</MedlineTA><NlmUniqueID>8611905</NlmUniqueID><ISSNLinking>0882-2786</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001688">Biological Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D055396">Bone Morphogenetic Protein 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015921">Dental Implants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499469">recombinant human bone morphogenetic protein-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000540" MajorTopicYN="N">Alveolar Ridge Augmentation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001688" MajorTopicYN="N">Biological Products</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055396" MajorTopicYN="N">Bone Morphogenetic Protein 2</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016025" MajorTopicYN="N">Bone Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064987" MajorTopicYN="N">Cell- and Tissue-Based Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003758" MajorTopicYN="N">Dental Implantation, Endosseous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015921" MajorTopicYN="N">Dental Implants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008437" MajorTopicYN="N">Maxilla</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008443" MajorTopicYN="N">Maxillary Sinus</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009066" MajorTopicYN="N">Mouth, Edentulous</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053657" MajorTopicYN="N">Platelet-Rich Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023822" MajorTopicYN="N">Tissue Engineering</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27228246</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000262 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000262 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:27228246
|texte= Biologics and Cell Therapy Tissue Engineering Approaches for the Management of the Edentulous Maxilla: A Systematic Review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:27228246" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |